Keyword: Pharmaceuticals

Chemistry & Life Sciences

PCRAMS is a Booming Business

16.01.2014 - Global Growth - Milan-based Chemical Pharmaceutical Association (CPA) recently published the report "The World Pharmaceutical Contract Research and Manufacturing Services Industry...

Chemistry & Life Sciences

Helsinn Reaps Benefits of Cytotoxic Molecule Demand

16.01.2014 - Strong Start - After beginning its investment in a brand-new cytotoxic molecule facility in Biasca, Switzerland, in 2011, Helsinn started production in July 2012. Now one and a...

News

Back in the Game

15.01.2014 - Poised For Growth - American Chemistry rang in the New Year with some cheer. Despite the challenges, the industry managed to post gains in 2013. American Chemistry is now poised...

News

Bayer and Regeneron Widen Wet AMD Partnership

14.01.2014 - Bayer HealthCare of Germany and its U.S. drug development partner Regeneron Pharmaceuticals have agreed to collaborate on Derived Growth Factor Receptor Beta (PDGFR-β) as a...

News

Bayer’s Eylea AMD Drug Hits Cost Evaluation Hurdle

06.01.2014 - Bayer HealthCare has hit a stumbling block in the sales campaign for its new drug Eylea (aflibercept), or VEGF Trap-Eye, recommended for treatment of age-related wet macula...

News

Bayer Confirms €42.80 per Share Bid for Algeta

30.12.2013 - Germany's Bayer finally confirmed its plans to acquire Norwegian pharmaceutical company Algeta shortly before Christmas. The German chemicals and pharmaceuticals group said Algeta...

News

Bundestag Keeps Drug Price Freeze in place

23.12.2013 - In contrast to speculation only days earlier, Germany's national parliament, the Bundestag, on 19 December passed pharmaceuticals legislation extending the mandatory discount...

News

Kemal Malik appointed Bayer AG Board of Management member with responsibility for Innovation

20.12.2013 - The Supervisory Board of Bayer AG appointed Kemal Malik (51) to the Board of Management of Bayer AG effective February 1, 2014. Malik has been a member of the Bayer HealthCare...